インドのファンドマネージャーは4月、製薬会社やノンバンク（非銀行金融会社）に新規投資を行った。これは、原油価格や西アジアの緊張をめぐる懸念の中で、ディフェンシブ銘柄をターゲットにした動きである。
セマグルチドの特許満期といった機会があることから、製薬企業が特に注目を集めた。株式運用ファンドの買い付け対象には、Aurobindo Pharma、Sun Pharma、Torrent Pharma、Mankind Pharmaといった銘柄が含まれている。
AIによるレポート AIによって生成された画像
Indian equity benchmarks Sensex and Nifty posted their strongest single-day gains in years on Wednesday, driven by a US-Iran ceasefire that eased oil prices and inflation fears. The market capitalization of BSE-listed companies rose by ₹16.1 lakh crore. However, Asian stocks turned cautious as the ceasefire showed signs of fragility.
India's small-cap stocks surged 17.1% in April, marking their best monthly performance in at least a decade. The Nifty Smallcap 250 index rebounded sharply after a steep sell-off in March. Local investors snapped up undervalued stocks with strong growth potential.
AIによるレポート
Retail investors put ₹38,440 crore into equity mutual funds last month, a modest decline from March levels. The dip occurred amid uncertainty over oil prices and lower SIP collections.
Equity mutual fund inflows dropped sharply in May to a 12-month low. The decline came amid concerns over the West Asia conflict. Systematic Investment Plan flows stayed largely steady.
AIによるレポート
Foreign portfolio investors have reduced cash market selling in Indian stocks but continue to show caution through derivatives positions. The moves come amid a modest gain in the Nifty index.
Nine BSE smallcap companies delivered standout performances in the March 2026 quarter, with net profits surging over 50% year-on-year and share prices rising 50% to 170% in the past year. Four of these stocks became multibaggers, more than doubling investor returns. Data from ACE Equity highlights the momentum amid mixed results from 168 reporting firms.
AIによるレポート
Equity margin funding rebounded in April, with the average MTF book reaching ₹1.14 lakh crore. The increase signals renewed investor confidence following March's market sell-off.